Cynthia L Hart

Title: Cynthia L Hart: Innovator in Anti-Galanin Antibodies

Introduction

Cynthia L Hart is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target galanin peptides. Her work has implications for the treatment and management of hyperproliferative disorders.

Latest Patents

Cynthia holds a patent for "Anti-galanin antibodies and uses thereof." This invention provides antibodies that immunospecifically bind to a galanin peptide and includes compositions comprising these antibodies. The patent outlines methods for preventing, treating, managing, and ameliorating hyperproliferative disorders or symptoms thereof by administering these antibodies to subjects in need. Additionally, the invention encompasses methods and compositions for diagnosing, monitoring, and prognosing hyperproliferative disorders. It also relates to articles of manufacture and kits that include these antibodies.

Career Highlights

Cynthia is associated with Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to focus on innovative solutions in the field of medical research and development. With a patent portfolio that includes 1 patent, she has established herself as a key figure in her area of expertise.

Collaborations

Cynthia has collaborated with notable colleagues, including Wade Aaron and Richard J Austin. These partnerships have contributed to her success and the advancement of her research initiatives.

Conclusion

Cynthia L Hart is a trailblazer in the field of biotechnology, with her innovative work on anti-galanin antibodies paving the way for new treatments for hyperproliferative disorders. Her contributions continue to impact the medical community positively.